Roche at the World Health Summit 2026. As global health leaders gather in Berlin for the World Health Summit 2026, we have a vital opportunity to address a fundamental question: how do we shift healthcare from being treated as a short-term budget line to a primary driver of economic stability?
The World Cancer Congress 2026 advances global cancer care through flexible models, early detection, and equity. Roche’s diagnostics and medicines offer a full perspective from detection to ongoing care.
Discover the symptoms, risk factors and treatment options of uveitic macular edema (UME), a serious eye disease that can cause vision loss and blindness.
AI-enabled algorithms are transforming diabetes care by predicting nighttime lows up to 7 hours in advance. Real-world data shows a 31% drop in severe hypoglycemia, offering proactive safety and peace of mind.
Learn about haemophilia A in infants, its impact on families, key symptoms to watch for, and why early diagnosis and prophylactic treatment are crucial for better outcomes.
Scott, an HR professional and coach in Basel, suddenly found himself in uncharted territory—facing medical uncertainty and personal resilience. As a passionate part-time drummer, he's determined not to miss a beat in his search for answers.
Raising awareness of the links between diabetes, obesity and heart health and exploring how personalised care is needed to achieve best outcomes for people living with diabetes
Learn about diabetic eye diseases, including diabetic retinopathy (DR) and diabetic macular edema (DME), their risks, symptoms and advanced treatment options to help prevent vision loss.
Roche is rethinking obesity and cardiometabolic care—connecting early diagnosis, treatment, and monitoring to build a personalised, long-term care model.
Diagnosed with type 1 diabetes in 1985, Hanna Boëthius faced significant struggles due to the limited tools available. Over the years, advancements in technology have transformed diabetes management.